ChestView US is an AI-enabled medical device from Gleamer SAS, listed by FDA (510(k), K241620) with a decision date of 2025-02-27. Review panel: Radiology.
| FDA submission number | K241620 |
|---|---|
| Pathway | 510(k) |
| Company | Gleamer SAS |
| Review panel (specialty) | Radiology |
| FDA decision date | 2025-02-27 |
| Decision | Substantially Equivalent |
| Product code | MYN |
| Classification | Analyzer, Medical Image |
| Device class | 2 |
| Regulation number | 892.2070 |
| Review time (calendar days) | 267 |
| Applicant country | FR |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.